(Press-News.org) CHICAGO – Among patients with either coronary artery disease (CAD) risk factors only, known prior heart attack, or known CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular events that included cardiovascular death, nonfatal heart attack or nonfatal stroke, according to a study in the October 3 issue of JAMA.
"Treatment with beta-blockers remains the standard of care for patients with coronary artery disease, especially when they have had a myocardial infarction [MI; heart attack]. The evidence is derived from relatively old post-MI studies, most of which antedate modern reperfusion or medical therapy, and from heart failure trials, but has been widely extrapolated to patients with CAD and even to patients at high risk for but without established CAD. It is not known if these extrapolations are justified. Moreover, the long-term efficacy of these agents in patients treated with contemporary medical therapies is not known, even in patients with prior MI," according to background information in the article.
Sripal Bangalore, M.D., M.H.A., of the NYU School of Medicine, New York, and colleagues conducted a study to evaluate the association between beta-blocker use and long-term cardiovascular outcomes. The observational study included data from patients in the Reduction of Atherothrombosis for Continued Health (REACH) registry. From this registry, 44,708 patients met the study inclusion criteria of whom 14,043 patients (31 percent) had prior MI, 12,012 patients (27 percent) had documented CAD but without MI, and 18,653 patients (42 percent) had CAD risk factors only. The last follow-up data collection was April 2009. The primary outcome for this study was a composite of cardiovascular death, nonfatal MI, or nonfatal stroke. The secondary outcome was the primary outcome plus hospitalization for atherothrombotic events or a revascularization procedure. The overall median (midpoint) follow-up was 44 months. Among the 44,708 patients in the study, 21,860 were included in the propensity score-matched analysis.
The researchers found that in the prior MI group, the event rates were not significantly different among those with beta-blocker use (489 [16.93 percent]) vs. those without beta-blocker use (532 [18.60 percent]) for the primary outcome, or the secondary outcome (30.96 percent vs. 33.12 percent, respectively). In the CAD without MI cohort, the event rates were not different in those with beta-blocker use (391 [12.94 percent]) vs. those without p-blocker use (405 [13.55 percent]) for the primary outcome, for cardiovascular death, for stroke, and for MI. The event rates were higher in those with beta-blocker use (1,101 [30.59 percent] vs. those without beta-blocker use (1,002 [27.84 percent]) for the secondary outcome and for hospitalization in the propensity score-matched model.
In the risk factors alone group, the event rates were higher in those with beta-blocker use (467 [14.22 percent] vs. those without beta-blocker use (403 [12.11 percent]) for the primary outcome, for the secondary outcome (870 [22.01 percent] vs. 797 [20.17 percent], respectively) but not for MI or stroke. In the propensity score-matched model, there were similar event rates for cardiovascular death and for hospitalization.
The researchers also found that among patients with recent MI (one year or less), beta-blocker use was associated with a lower incidence of the secondary outcome.
"Among patients enrolled in the international REACH registry, beta-blocker use was not associated with a lower event rate of cardiovascular events at 44-month follow-up, even among patients with prior history of MI. Further research is warranted to identify subgroups that benefit from beta-blocker therapy and the optimal duration of beta-blocker therapy," the authors conclude.
###
(JAMA. 2012;308[13]:1340-1349. Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Sripal Bangalore, M.D., M.H.A., call Allison Clair at 212-404-3753 or email allison.clair@nyumc.org.
Beta-blocker use not associated with lower risk of cardiovascular events
2012-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Patients with rheumatoid arthritis appear to be at increased risk for blood clots
2012-10-03
CHICAGO – A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
"Recent reports suggest that rheumatoid arthritis (RA) may be a risk factor for venous thromboembolism (VTE), particularly in conjunction with hospitalization. Using hospitalization data to identify RA and ...
Cardiac medication may help reduce stiffness caused by certain muscle diseases
2012-10-03
CHICAGO – Preliminary research finds that for patients with nondystrophic myotonias (NDMs), rare diseases that affect the skeletal muscle and cause functionally limiting stiffness and pain, use of the anti-arrhythmic medication mexiletine resulted in improvement in patient-reported stiffness, according to a preliminary study in the October 3 issue of JAMA.
Data on treatment of NDMs are largely anecdotal, consisting of case series and a single-blind, controlled trials of several medications including mexiletine, according to background information in the article.
Jeffrey ...
The genetics of HIV-1 resistance
2012-10-03
Drug resistance is a major problem when treating infections. This problem is multiplied when the infection, like HIV-1, is chronic. New research published in BioMed Central's open access journal Retrovirology has examined the genetic footprint that drug resistance causes in HIV and found compensatory polymorphisms that help the resistant virus to survive.
Currently the strategy used to treat HIV-1 infection is to prevent viral replication, measured by the number of viral particles in the blood, and to repair the immune system, assessed using CD4 count. Over the past 20 ...
Balancing fertility and child survival in the developing world
2012-10-03
Children in smaller families are only slightly more likely to survive childhood in high mortality environments, according to a new study of mothers and children in sub-Saharan Africa seeking to understand why women, even in the highest fertility populations in world, rarely give birth to more than eight children.
The study by Dr David Lawson and Dr Alex Alvergne from UCL Anthropology, and Dr Mhairi Gibson from the University of Bristol, challenges the popular theory proposed by evolutionary anthropologists that natural selection sets the upper limit of high fertility to ...
State-mandated planning, higher resident wealth linked to more sustainable city transportation
2012-10-03
COLUMBUS, Ohio – Transportation practices tend to be more environmentally friendly in wealthier metropolitan areas located within states that mandate comprehensive planning, new research suggests.
The study involved an examination of 225 U.S. metropolitan areas between 1980 and 2008 to gauge how sustainable their transportation practices were and determine what kinds of socioeconomic factors appeared to influence those practices.
Overall, transportation has become less sustainable across the country over this period, but some communities have slowed the decline more ...
Study confirms link between indoor tanning and skin cancer risk
2012-10-03
Indoor tanning increases the risks of developing non-melanoma skin cancer (known as basal cell carcinoma and squamous cell carcinoma), particularly among those exposed before the age of 25, finds a study published on bmj.com today.
It follows a BMJ study published in July that showed 3,438 (5.4%) new cases of melanoma diagnosed each year in Western Europe are related to sunbed use, particularly among young adults.
Some experts are now calling for Europe to follow the example of the United States by introducing a "tan tax" on indoor tanning salons.
The researchers, ...
Doctors speak out about unnecessary care as cost put at $800 billion a year
2012-10-03
Leading doctors are calling for action to tackle unnecessary care that is estimated to account for up to $800bn in the United States every year.
In a special report for this week's BMJ, journalist Jeanne Lenzer describes how a new movement led by prominent doctors is challenging the basic assumption in US healthcare that more is better.
The report comes as an international conference 'Preventing Overdiagnosis' is announced for September 2013 in the United States, hosted by The Dartmouth Institute for Health Policy and Clinical Practice, in partnership with the BMJ, ...
New firework causes severe eye injuries, warn doctors
2012-10-03
A new type of firework caused severe eye injuries and blindness in children and adults at last year's bonfire night celebrations, warn doctors in a letter to this week's BMJ.
Edward Pringle and colleagues describe how on the evening of 5 November 2011, eight patients attended the Sussex Eye Hospital, five with serious eye injuries - two were blinded and the other three have a lifelong glaucoma risk.
Police inquiries suggest the new explosive was derived from "rope banger deer scarers," which have a slow burning rope fuse that ignites several explosives along the rope. ...
Tanning beds linked to non-melanoma skin cancer
2012-10-03
Indoor tanning beds can cause non-melanoma skin cancer – and the risk is greater the earlier one starts tanning, according to a new analysis led by UCSF.
Indoor tanning is already an established risk factor for malignant melanoma, the less common but deadliest form of skin cancer. Now, the new study confirms that indoor tanning significantly increases the risk of non-melanoma skin cancers, the most common human skin cancers.
In the most extensive examination of published findings on the subject, the researchers estimate that indoor tanning is responsible for more ...
Allergy rises not down to being too clean, just losing touch with 'old friends'
2012-10-03
A new scientific report out today from the International Scientific Forum on Home Hygiene (IFH) dismantles the myth that the epidemic rise in allergies in recent years has happened because we're living in sterile homes and overdoing hygiene.
But far from saying microbial exposure is not important, the report concludes that losing touch with microbial 'old friends' may be a fundamental factor underlying rises in an even wider array of serious diseases. As well as allergies, there are numerous other 'chronic inflammatory diseases' (CIDs) such as Type 1 diabetes and multiple ...